Population-based Assessment of Survival After Cytoreductive Nephrectomy Versus No Surgery in Patients With Metastatic Renal Cell Carcinoma (Q59649595)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

metastatic renal cell carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Claudio Jeldres

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

10

Pierre I Karakiewicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

3

Paul Perrotte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

8

Francesco Montorsi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

5

Shahrokh F Shariat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

7

Hugues Widmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

6

Philippe Arjane

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

Laurent Zini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Jean-Jacques Patard

series ordinal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

28 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

342-346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Selection of patients may limit the generalizability of results from cancer trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Randomisation to protect against selection bias in healthcare trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Outcome and survival with nonsurgical management of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Targeted therapy in metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

Integrated therapy of kidney cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.09.022

10.1016/J.UROLOGY.2008.09.022

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19041122%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference